LISATA THERAPEUTICS, INC. Marketable Securities, Unrealized Gain (Loss)
LISATA THERAPEUTICS, INC. (LSTA) reported Marketable Securities, Unrealized Gain (Loss) of $34.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-05.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLoss · last filed 2020-03-05
- LISATA THERAPEUTICS, INC. marketable securities, unrealized gain (loss) for fiscal 2019 was $34.00K.
- LISATA THERAPEUTICS, INC. marketable securities, unrealized gain (loss) for fiscal 2018 was -$4.00K.
- LISATA THERAPEUTICS, INC. marketable securities, unrealized gain (loss) for fiscal 2017 was -$28.00K.
- LISATA THERAPEUTICS, INC. marketable securities, unrealized gain (loss) for fiscal 2016 was -$486.00.
| Period end | Marketable Securities, Unrealized Gain (Loss) 12 month | Marketable Securities, Unrealized Gain (Loss) 12 month as first filed |
|---|---|---|
| 2019-12-31 | $34.00K 10-K · filed 2020-03-05 | |
| 2018-12-31 | -$4.00K 10-K · filed 2020-03-05 | |
| 2017-12-31 | -$28.00K 10-K · filed 2019-03-14 | -$27.98K 10-K · filed 2018-03-22 |
| 2016-12-31 | -$486.00 10-K · filed 2018-03-22 | |
| 2015-12-31 | -$843.00 10-K · filed 2017-03-17 | |
| 2014-12-31 | $1.33K 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |